AWM
MRNA icon

Axxcess Wealth Management’s Moderna MRNA Stock Holding History

Axxcess Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,159
Closed -$430K – 901
2023
Q3 		$430K Buy
4,159
+2,127
+105% +$237K 0.01% 512
2023
Q2 		$247K Buy
2,032
+510
+34% +$68K 0.02% 506
2023
Q1 		$234K Hold
1,522
– – 0.02% 549
2022
Q4 		$273K Buy
+1,522
New +$249K 0.02% 470
2022
Q2 		– Sell
-1,186
Closed -$204K – 611
2022
Q1 		$204K Sell
1,186
-1,938
-62% -$326K 0.02% 585
2021
Q4 		$793K Buy
+3,124
New +$913K 0.06% 257

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Axxcess Wealth Management's MRNA Position: Q4 2023 in Review

Axxcess Wealth Management sold out of Moderna (MRNA) in Q4 2023, closing a stake of 4,159 shares — an estimated $430K sold.

Axxcess Wealth Management first reported a position in MRNA in Q4 2021 and held it in 6 quarters. The position peaked at $793K in Q4 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Axxcess Wealth Management reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Axxcess Wealth Management sold 4,159 Moderna shares in Q4 2023, an estimated $430K.
  • Axxcess Wealth Management first reported a position in Moderna in Q4 2021 and held it in 6 quarters.
  • Axxcess Wealth Management's Moderna position peaked at $793K in Q4 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Axxcess Wealth Management's 13F filing for Q4 2023, filed 6 Feb 2024.